NXP-2 association with SUMO-2 depends on lysines required for transcriptional repression

  1. Adam Rosendorff*,
  2. Shuhei Sakakibara*,
  3. Sixin Lu*,
  4. Elliott Kieff*,,
  5. Yan Xuan,
  6. Alessandra DiBacco,
  7. Yujiang Shi,
  8. Yang Shi, and
  9. Grace Gill
  1. *Department of Medicine and Department of Microbiology and Molecular Genetics, Channing Laboratory, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115; and
  2. Department of Pathology, Harvard Medical School, Boston, MA 02115
  1. Contributed by Elliott Kieff, February 8, 2006

Abstract

Small ubiquitin-like modifier (SUMO) modification of transcription factors is generally associated with repression. Reverse genetic analysis of SUMO-1, and -2 conserved residues emphasized the importance of dual charge reversals in abrogating the critical role of SUMO-2 K33, K35, and K42 in repression. GST-SUMO-2-affinity chromatography followed by liquid chromatography (LC)-MS analysis identified proteins that appeared to bind preferentially to WT SUMO-2 versus SUMO-2 K33E and K35E. LSD1, NXP-2, KIAA0809 (ARIP4), SAE2, RanGAP1, PELP1, and SETDB1 bound to SUMO-2 and not to SUMO-2 K33E, K42E, or K35E and K42E. Although LSD1 is a histone lysine demethylase, and histone H3K4 was demethylated at a SUMO-2-repressed promoter, neither overexpression of a dominant-negative LSD1 nor LSD1 depletion with RNA interference affected SUMO-2-mediated repression, indicating that LSD1 is not essential for repression, in this context. When tethered to a promoter by fusion to Gal4, NXP-2 repressed transcription, consistent with a role for NXP-2 in SUMO-mediated repression. SUMO-2-associated proteins identified in this study may contribute to SUMO-dependent regulation of transcription or other processes.

Footnotes

  • To whom correspondence should be addressed at:
    Channing Laboratory, 181 Longwood Avenue, Boston, MA 02114.
    E-mail: ekieff{at}rics.bwh.harvard.edu
  • Author contributions: A.R., S.S., E.K., A.D., and G.G. designed research; A.R., S.S., S.L., Y.X., and A.D. performed research; Yujiang Shi and Yang Shi contributed new reagents/analytic tools; A.R., S.S., S.L., E.K., Y.X., A.D., and G.G. analyzed data; and A.R., S.S., E.K., and G.G. wrote the paper.

  • Conflict of interest statement: No conflicts declared.

  • Abbreviations:

    Abbreviation:

    SUMO,
    small ubiquitin-like modifier.
« Previous | Next Article »Table of Contents